NCT06459648View on ClinicalTrials.gov

Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Migraine
Interventions
OTHER

Headache record

The patient will keep a record of the presence/absence of headache, average intensity, and need for acute medication.

OTHER

Scales

Each patient performs different scales that measure the impact of the migraine on their daily life as well as the disability it may be causing. In turn, each patient performs different scales that measure associated comorbidities such as depression, anxiety or insomnia.

DRUG

Monoclonal antibody anti-CGRP

Erenumab, Galcenazumeb, Fremanezumab, Eptinezumab

Trial Locations (7)

20014

RECRUITING

Hospital Universitario Donostia, Donostia / San Sebastian

28006

RECRUITING

Hospital Universitario de La Princesa, Madrid

39008

RECRUITING

Hospital Universitario Marqués de Valdecilla, Santander

46026

RECRUITING

Hospital Universitario Politécnico La Fe, Valencia

47010

RECRUITING

Hospital Clínico Universitario de Valladolid, Valladolid

50009

RECRUITING

Hospital Clínico Universitario Lozano Blesa, Zaragoza

08035

RECRUITING

Hospital Universitari Vall d'Hebron Research Institute, Barcelona

All Listed Sponsors
lead

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

OTHER